Kemmerer CL, Pernpeintner V, Ruschil C, Abdelhak A, et al. Differential effects of disease modifying drugs on peripheral blood B cell subsets: A cross sectional study in multiple sclerosis patients treated with interferon-beta, glatiramer acetate, dimethyl fumarate, fingolimod or natalizumab. PLoS One 2020;15:e0235449.
PMID: 32716916